Patent · US Active

Glucagon like peptide 1 (GLP1)-growth differentiation factor 15 (GDF15) fusion proteins and uses thereof

US11713345B2 · kind B2 · utility

1Cited by

1References

11Claims

0Family size

Assignee

Janssen Sciences Ireland Unlimited Company · IE

Inventors

Shannon Mullican · Philadelphia, US
Matthew M. RANKIN · Spring House, US
Xiefan Lin-Schmidt · Ambler, US
Chichi Huang · Malvern, US
Jennifer Furman · Tucson, US
Songmao Zheng · Spring House, US
Shamina M. Rangwala · Furlong, US
Serena Nelson · San Diego, US

Key dates

Filing date	Oct 22, 2019
Grant date	Aug 1, 2023
Priority date	—
Expiry date	Oct 22, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/31
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are GLP1-GDF15 fusion proteins comprising a GLP1 or GLP1 variant peptide, a first linker peptide, a serum albumin protein, a second linker peptide, and a GDF15 protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.